Different effects of nabilone and cannabidiol on binocular depth inversion in man

被引:111
作者
Leweke, FM [1 ]
Schneider, U [1 ]
Radwan, M [1 ]
Schmidt, E [1 ]
Emrich, HM [1 ]
机构
[1] Hannover Med Sch, Dept Clin Psychiat & Psychotherapy, D-30623 Hannover, Germany
关键词
cannabinoids; cannabidiol; nabilone; binocular depth inversion; humans;
D O I
10.1016/S0091-3057(00)00201-X
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The physiological and pathophysiological roles of the central nervous endogenous cannabinoid system are not completely understood, but still represent a challenge in basic neurobiological, cognitive, and psychiatric research. The system has been implicated in the pathogenesis of schizophrenia. Binocular depth inversion, an illusion of visual perception, provides a model of impaired perception during psychotic states. Using this model the effects of nabilone, a psychoactive synthetic 9-trans-keto-cannabinoid, and of cannabidiol, the main natural component of herbal cannabis, and a combined application of both substances on binocular depth inversion and behavioural states were investigated in nine healthy male volunteers. The time course of the effects of both substances on binocular depth inversion was analysed after oral administration using three different groups of natural stimuli. A significant impairment of binocular depth perception was found when nabilone was administered, but combined application with cannabidiol revealed somewhat reduced effects on binocular depth inversion. The influence of psychoactive cannabinoids on this perceptual model and the role of the endogenous cannabinoid system in visual information processing are discussed. (C) 2000 Elsevier Science Inc.
引用
收藏
页码:175 / 181
页数:7
相关论文
共 51 条
[1]  
[Anonymous], 1852, PHILOS T ROYAL SOC, DOI DOI 10.1098/RSTL.1852.0001
[2]   THE PROBLEM OF CONSCIOUSNESS [J].
CRICK, F ;
KOCH, C .
SCIENTIFIC AMERICAN, 1992, 267 (03) :153-159
[3]   CHRONIC ADMINISTRATION OF CANNABIDIOL TO HEALTHY-VOLUNTEERS AND EPILEPTIC PATIENTS [J].
CUNHA, JM ;
CARLINI, EA ;
PEREIRA, AE ;
RAMOS, OL ;
PIMENTEL, C ;
GAGLIARDI, R ;
SANVITO, WL ;
LANDER, N ;
MECHOULAM, R .
PHARMACOLOGY, 1980, 21 (03) :175-185
[4]  
DALTON WS, 1976, CLIN PHARMACOL THER, V19, P300
[5]  
DEVANE WA, 1988, MOL PHARMACOL, V34, P605
[6]   ISOLATION AND STRUCTURE OF A BRAIN CONSTITUENT THAT BINDS TO THE CANNABINOID RECEPTOR [J].
DEVANE, WA ;
HANUS, L ;
BREUER, A ;
PERTWEE, RG ;
STEVENSON, LA ;
GRIFFIN, G ;
GIBSON, D ;
MANDELBAUM, A ;
ETINGER, A ;
MECHOULAM, R .
SCIENCE, 1992, 258 (5090) :1946-1949
[7]   REDUCED BINOCULAR DEPTH INVERSION AS AN INDICATOR OF CANNABIS-INDUCED CENSORSHIP IMPAIRMENT [J].
EMRICH, HM ;
WEBER, MM ;
WENDL, A ;
ZIHL, J ;
VONMEYER, L ;
HANISCH, W .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1991, 40 (03) :689-690
[8]   Towards a cannabinoid hypothesis of schizophrenia: Cognitive impairments due to dysregulation of the endogenous cannabinoid system [J].
Emrich, HM ;
Leweke, FM ;
Schneider, U .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1997, 56 (04) :803-807
[10]   THE EFFICACY AND SAFETY OF NABILONE (A SYNTHETIC CANNABINOID) IN THE TREATMENT OF ANXIETY [J].
FABRE, LF ;
MCLENDON, D .
JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (8-9) :S377-S382